Cargando…
Amiodarone Use and All‐Cause Mortality in Patients With a Continuous‐Flow Left Ventricular Assist Device
BACKGROUND: Atrial and ventricular arrhythmias are commonly encountered in patients with advanced heart failure, with amiodarone being the most commonly used antiarrhythmic drug in continuous‐flow left ventricular assist device (CF‐LVAD) recipients. The purpose of this study was to assess the impact...
Autores principales: | Gopinathannair, Rakesh, Pothineni, Naga Venkata K., Trivedi, Jaimin R., Roukoz, Henri, Cowger, Jennifer, Ahmed, Mustafa M., Bhan, Adarsh, K. Ravichandran, Ashwin, Bhat, Geetha, Al Ahmad, Amin, Natale, Andrea, Di Biase, Luigi, Slaughter, Mark S., Lakkireddy, Dhanunjaya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238747/ https://www.ncbi.nlm.nih.gov/pubmed/35656998 http://dx.doi.org/10.1161/JAHA.121.023762 |
Ejemplares similares
-
Implantable cardioverter-defibrillator–related procedures and associated complications in continuous flow left ventricular assist device recipients: A multicenter experience
por: Ravichandran, Ashwin, et al.
Publicado: (2021) -
Continued versus Suspended Cardiac Resynchronization Therapy after Left Ventricular Assist Device Implantation
por: Roukoz, Henri, et al.
Publicado: (2020) -
Questionable utility of digoxin in left-ventricular assist device recipients: A multicenter, retrospective analysis
por: Ahmed, Mustafa M., et al.
Publicado: (2019) -
Cardiac Resynchronization Therapy and Clinical Outcomes in Continuous Flow Left Ventricular Assist Device Recipients
por: Gopinathannair, Rakesh, et al.
Publicado: (2018) -
Role of Digital Health During Coronavirus Disease 2019 Pandemic and Future Perspectives
por: Ahmed, Adnan, et al.
Publicado: (2022)